UY36355A - Compuestos de carboxilato de fenilcetona y composicionesfarmacéuticas para la prevención y tratamiento de osteoporosis - Google Patents

Compuestos de carboxilato de fenilcetona y composicionesfarmacéuticas para la prevención y tratamiento de osteoporosis

Info

Publication number
UY36355A
UY36355A UY0001036355A UY36355A UY36355A UY 36355 A UY36355 A UY 36355A UY 0001036355 A UY0001036355 A UY 0001036355A UY 36355 A UY36355 A UY 36355A UY 36355 A UY36355 A UY 36355A
Authority
UY
Uruguay
Prior art keywords
osteoporosis
prevention
treatment
pharmaceutical compositions
carboxylate compounds
Prior art date
Application number
UY0001036355A
Other languages
English (en)
Inventor
Gagnon Lyne
Grouix Brigitte
Original Assignee
Prometic Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prometic Biosciences Inc filed Critical Prometic Biosciences Inc
Publication of UY36355A publication Critical patent/UY36355A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/86—Unsaturated compounds containing keto groups containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Abstract

La presente invención se refiere al uso de compuestos para prevenir y/o tratar la osteoporosis, para estimular la formación ósea, para estimular la remodelación ósea, para estimular la diferenciación y la mineralización de los osteoblastos, o para inhibir la resorción ósea en un sujeto. Estos usos novedosos se han descubierto para los compuestos representados por la fórmula I descritos en la presente solicitud y las sales farmacéuticamente aceptables de estos.
UY0001036355A 2014-10-10 2015-10-13 Compuestos de carboxilato de fenilcetona y composicionesfarmacéuticas para la prevención y tratamiento de osteoporosis UY36355A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462062660P 2014-10-10 2014-10-10

Publications (1)

Publication Number Publication Date
UY36355A true UY36355A (es) 2016-06-01

Family

ID=55652426

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001036355A UY36355A (es) 2014-10-10 2015-10-13 Compuestos de carboxilato de fenilcetona y composicionesfarmacéuticas para la prevención y tratamiento de osteoporosis

Country Status (22)

Country Link
US (1) US10925846B2 (es)
EP (1) EP3204000B1 (es)
JP (1) JP6700638B2 (es)
KR (1) KR20170066613A (es)
CN (1) CN106999459B (es)
AR (1) AR102247A1 (es)
AU (1) AU2015330642B2 (es)
BR (1) BR112017007386A2 (es)
CA (1) CA2963358C (es)
DK (1) DK3204000T3 (es)
ES (1) ES2794782T3 (es)
IL (1) IL251409B (es)
MX (1) MX2017004735A (es)
MY (1) MY187511A (es)
PH (1) PH12017500636A1 (es)
PL (1) PL3204000T3 (es)
PT (1) PT3204000T (es)
RU (1) RU2712027C2 (es)
SG (1) SG11201702810TA (es)
TW (1) TWI723962B (es)
UY (1) UY36355A (es)
WO (1) WO2016054725A1 (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7863270B2 (en) * 2005-05-13 2011-01-04 Synta Pharmaceuticals Corp. IL-12 modulatory compounds
EP2488208B1 (en) * 2009-10-14 2018-11-21 The Governors of the University of Alberta Compounds having peptides conjugated to bone targeting moieties and methods of making and using thereof
MY162420A (en) * 2010-10-27 2017-06-15 Prometic Pharma Smt Ltd Compounds and compositions for the treatment of cancer
JP6055771B2 (ja) * 2010-10-27 2016-12-27 プロメティック・ファーマ・エスエムティ・リミテッドＰｒｏｍｅｔｉｃ Ｐｈａｒｍａ Ｓｍｔ Ｌｉｍｉｔｅｄ カルボン酸フェニルケトン化合物およびその薬学的使用
TW201305098A (zh) * 2010-10-27 2013-02-01 Prometic Biosciences Inc 用於糖尿病的化合物和藥物組合物
WO2014138372A1 (en) * 2013-03-06 2014-09-12 Primavera Biosciences, Inc. Composition and method for treating osteoarthritis

Also Published As

Publication number Publication date
TWI723962B (zh) 2021-04-11
AR102247A1 (es) 2017-02-15
DK3204000T3 (da) 2020-04-06
IL251409A0 (en) 2017-05-29
JP2017530179A (ja) 2017-10-12
WO2016054725A1 (en) 2016-04-14
US10925846B2 (en) 2021-02-23
US20190038580A1 (en) 2019-02-07
EP3204000A1 (en) 2017-08-16
TW201618761A (zh) 2016-06-01
SG11201702810TA (en) 2017-05-30
JP6700638B2 (ja) 2020-05-27
MX2017004735A (es) 2017-11-17
RU2017116154A3 (es) 2019-05-06
AU2015330642A1 (en) 2017-05-11
ES2794782T3 (es) 2020-11-19
RU2017116154A (ru) 2018-11-12
BR112017007386A2 (pt) 2018-01-23
CN106999459A (zh) 2017-08-01
KR20170066613A (ko) 2017-06-14
EP3204000A4 (en) 2018-06-20
CA2963358C (en) 2023-03-07
CN106999459B (zh) 2020-07-10
PH12017500636A1 (en) 2017-09-25
IL251409B (en) 2020-08-31
RU2712027C2 (ru) 2020-01-27
PL3204000T3 (pl) 2020-07-27
CA2963358A1 (en) 2016-04-14
MY187511A (en) 2021-09-24
PT3204000T (pt) 2020-05-06
AU2015330642B2 (en) 2019-07-04
EP3204000B1 (en) 2020-01-08

Similar Documents

Publication Publication Date Title
PH12018500040A1 (en) Indazole and azaindazole compounds as irak-4 inhibitors
PH12018500041A1 (en) Substituted aza compoounds as irak-4 inhibitors
CL2018002009A1 (es) Compuestos derivados de ciclopentanoperhidofenantreno, moduladores de fxr; composicion farmaceutica que comprende dichos compuestos; y su uso para el tratamiento de enfermedades colestásicas, fibróticas, hipercolesterolemia, entre otras.
PH12016502382A1 (en) Substituted indazole compounds as irak4 inhibitors
CL2017001204A1 (es) Derivados de 6-amino-7-biciclo-7-deaza-purina como inhibidores de la proteína quinasa
MY195427A (en) Jak Kinase Inhibitor Compounds for Treatment of Respiratory Disease
DOP2015000274A (es) Compuestos químicos
EA202090486A2 (ru) Соединения для лечения спинальной мышечной атрофии
DOP2015000158A (es) Inhibidores de prmt5 y sus usos
BR112017013491A2 (pt) compostos de pirimidina fundida para o tratamento de hiv
CR20160523A (es) Compuestos de imidazo[4,5-c]quinolin-2-ona y su uso para tratar cáncer
BR112017013440A2 (pt) compostos de isoquinolina para o tratamento de hiv
UY33479A (es) Compuestos terapeuticos, composicion farmaceutica que lo comprende, metodo de tratamiento y su uso para la manufactura de un medicamento
EA032928B1 (ru) Бициклические кетосульфонамидные соединения
UY33547A (es) COMPUESTOS QUÍMICOS Bcl-2 y Bcl-XL
EA201591406A1 (ru) C-19 модифицированные тритерпеноиды с ингибиторной активностью созревания вич
UY36356A (es) Compuestos aromáticos sustituidos y composiciones farmacéuticas para la prevención y tratamiento de osteoporosis
BR112017005242A2 (pt) composto, composição farmacêutica, e, composto para uso.
CY1122077T1 (el) Νεα δακτυλιωμενα φαινοξυακεταμιδια
EA201692260A1 (ru) Соединения 1,3,4-тиадиазола и их применение в лечении рака
CR20160460A (es) Heterociclos condensados sustituidos como moduladores de gpr119 para el tratamiento de la diabetes, obesidad, dislipidemia y trastornos relacionados
UY35359A (es) 7-OXO-PIRIDO[2,3-d]PIRIMIDINAS SUSTITUIDAS Y MÉTODOS DE USO
CL2017000827A1 (es) Inhibidores de aldosterona sintasa
CR20160529A (es) Composiciones farmacéuticas para tratar enfermedades infecciosas
EA201590364A1 (ru) Применение орвепитанта, его солей и кристаллических форм и композиций, его содержащих, для лечения зуда

Legal Events

Date Code Title Description
RDES Application refused

Effective date: 20230414